J Clin Nutr.  2015 Aug;7(2):42-48. 10.15747/jcn.2015.7.2.42.

Role of Parenteral Glutamine in Nutrition Support for Critically Ill Patients

• Park HJ

• KMID: 2043392
• DOI: http://doi.org/10.15747/jcn.2015.7.2.42

Abstract

Glutamine is the most abundant amino acid, composed of more than 50 percent of free amino acid in the human body. It had been regarded as a conditional essential amino acid and its concentration is markedly reduced in critically ill patients with trauma, burn, or sepsis. From the early 1990s, many parenteral glutamine studies on critical illness have reported the benefits in mortality, infection, and length of stay. However, its clinical efficacy was based on out-of-date, smaller, single-center studies. Clinical effects of parenteral glutamine have shown no benefits or even harms in recent clinical trials and meta-analysis. Furthermore, it has challenged the hypothesis that low plasma glutamine concentration was associated with poor outcomes in critically ill patients. Although many studies showing the efficacy of glutamine have been reported, parenteral glutamine supplementation may be harmful in patients with multiorgan failure or baseline kidney dysfunction. Further studies should be conducted to identify the use of glutamine supplementation in combination with parenteral and enteral nutrition or enteral/oral nutrition alone, specific adult or pediatric patients, the appropriate time and doses for administration of glutamine, cost-benefit analysis, and the exact mechanisms of action.

Keyword

Glutamine; Parenteral nutrition; Intensive care units

MeSH Terms

Adult
Burns
Cost-Benefit Analysis
Critical Illness*
Enteral Nutrition
Glutamine*
Human Body
Humans
Intensive Care Units
Kidney
Length of Stay
Mortality
Parenteral Nutrition
Plasma
Sepsis
Glutamine